{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:58:31Z","timestamp":1773424711768,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.healun.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T12:26:34Z","timestamp":1535631994000},"page":"1372-1380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients"],"prefix":"10.1016","volume":"37","author":[{"given":"Rabea","family":"Asleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen L.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooks S.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Frantz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-5313","authenticated-orcid":false,"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir S.","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2018.07.004_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the Achilles' heel of heart transplantation","volume":"68","author":"Chih","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.healun.2018.07.004_bib0002","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","article-title":"Cardiac allograft vasculopathy after heart transplantation: risk factors and management","volume":"23","author":"Valantine","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0003","first-page":"580","article-title":"The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients","volume":"12","author":"Lake","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0004","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199409000-00006","article-title":"The effect of FK506 versus cyclosporine on glucose and lipid metabolism\u2014a randomized trial","volume":"58","author":"Steinm\u00fcller","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0735-1097(01)01337-7","article-title":"Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study","volume":"38","author":"Kapadia","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2018.07.004_bib0006","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.tp.0000230378.61437.a5","article-title":"Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy","volume":"82","author":"Bae","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2018.07.004_bib0007","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.ATV.20.3.698","article-title":"Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease","volume":"20","author":"Holvoet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.healun.2018.07.004_bib0008","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2018.07.004_bib0009","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ahj.2004.03.050","article-title":"Treatment of hyperlipidemia in cardiac transplant recipients","volume":"148","author":"Bilchick","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.healun.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","article-title":"Simvastatin initiated early after heart transplantation: 8-year prospective experience","volume":"107","author":"Wenke","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.07.004_bib0011","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0012","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.healun.2011.01.720","article-title":"Prevention of transplant coronary artery disease by prenylation inhibitors","volume":"30","author":"Stein","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0013","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.healun.2007.02.006","article-title":"Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy","volume":"26","author":"Yin","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","article-title":"Use of rapamycin slows progression of cardiac transplant vasculopathy","volume":"108","author":"Mancini","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.07.004_bib0016","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.07.004_bib0017","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0018","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-term sirolimus for primary immunosuppression in heart transplant recipients","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2018.07.004_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","article-title":"Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study","volume":"103","author":"Sousa","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.07.004_bib0020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients","volume":"43","author":"Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.healun.2018.07.004_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12265-016-9719-8","article-title":"Sirolimus therapy is associated with elevation in circulating PCSK9 levels in cardiac transplant patients","volume":"10","author":"Simha","year":"2017","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.healun.2018.07.004_bib0022","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0023","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0024","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2018.07.004_bib0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0735-1097(92)90340-S","article-title":"Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations","volume":"19","author":"Ballantyne","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.healun.2018.07.004_bib0026","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/01.CIR.91.6.1706","article-title":"Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound","volume":"91","author":"Tuzcu","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.healun.2018.07.004_bib0027","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/ajt.12809","article-title":"Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial","volume":"14","author":"Andreassen","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2018.07.004_bib0028","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI10233","article-title":"Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis","volume":"107","author":"Hillebrands","year":"2001","journal-title":"J Clin Invest"},{"issue":"Suppl K","key":"10.1016\/j.healun.2018.07.004_bib0029","doi-asserted-by":"crossref","first-page":"K32","DOI":"10.4244\/EIJV7SKA6","article-title":"Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells","author":"Clever","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.healun.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0809136105","article-title":"Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation","volume":"105","author":"Choo","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2018.07.004_bib0031","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004106","article-title":"Rapamycin attenuates cardiac fibrosis in experimental uremic cardiomyopathy by reducing marinobufagenin levels and inhibiting downstream pro-fibrotic signaling","volume":"5","author":"Haller","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.healun.2018.07.004_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cvr\/cvm103","article-title":"Rapamycin modulates the eNOS vs. shear stress relationship","volume":"78","author":"Cheng","year":"2008","journal-title":"Cardiovasc Res"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818315432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249818315432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:35:35Z","timestamp":1760949335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249818315432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1053249818315432"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2018.07.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}